Phase II trial of low-dose intranasal testosterone [TBS 2; Tefina] in patients with anorgasmia: the Vibrotactile Stimulation Study.

Trial Profile

Phase II trial of low-dose intranasal testosterone [TBS 2; Tefina] in patients with anorgasmia: the Vibrotactile Stimulation Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2012

At a glance

  • Drugs Testosterone (Primary)
  • Indications Anorgasmia
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms VTS
  • Most Recent Events

    • 15 Feb 2012 Primary endpoint 'Sexual-satisfaction' (achievement of orgasm) has been met.
    • 14 Feb 2012 Results published in a Trimel Pharmaceuticals Corporation media release.
    • 19 Dec 2011 Final results will be presented at a Trimel R&D Event in February 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top